Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease
PLOS Biology · 23.07.2024 · 22 (7) · e3002727
DOI: 10.1371/journal.pbio.3002727 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 23.07.2024. Verfasst von Rikesh M Rajani und 18 weiteren Autor:innen. Beteiligte Einrichtung: UK Dementia Research Institute at UCL, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Disease Models, Animal, Mice, Transgenic. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Medical Research Council, MRC, UK Dementia Research Institute.
Themen: Demenz
Abstract (Originalsprache)
Reduction of amyloid beta (Aβ) has been shown to be effective in treating Alzheimer’s disease (AD), but the underlying assumption that neurons are the main source of pathogenic Aβ is untested. Here, we challenge this prevailing belief by demonstrating that oligodendrocytes are an important source of Aβ in the human brain and play a key role in promoting abnormal neuronal hyperactivity in an AD knock-in mouse model. We show that selectively suppressing oligodendrocyte Aβ production improves AD brain pathology and restores neuronal function in the mouse model in vivo. Our findings suggest that targeting oligodendrocyte Aβ production could be a promising therapeutic strategy for treating AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UK Dementia Research Institute at UCL, University College London, London, United Kingdom.
- Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London, United Kingdom.
- Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, United Kingdom.
- UK Dementia Research Institute at University of Cambridge, Cambridge, United Kingdom.
- School of Physics and Astronomy, University of St Andrews, St. Andrews, United Kingdom.
- Wolfson Institute for Biomedical Research, University College London, London, United Kingdom.
ORCID-Profile: Rikesh M Rajani, Marc Aurel Busche
Förderung
- UK Medical Research Council
- MRC
- UK Dementia Research Institute
- Medical Research Council
- National Centre for the Replacement, Refinement and Reduction of Animals in Research
- Alzheimer's Association
- National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre
- Alzheimer’s Association
Zitieren
APA
Rajani, R. M., Ellingford, R., Hellmuth, M., Harris, S. S., Taso, O. S., Graykowski, D., Lam, F. K. W., Arber, C., Fertan, E., Danial, J. S. H., Swire, M., Lloyd, M., Giovannucci, T. A., Bourdenx, M., Klenerman, D., Vassar, R., Wray, S., Sala Frigerio, C., & Busche, M. A. (2024). Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease. PLOS Biology, 22(7), e3002727. https://doi.org/10.1371/journal.pbio.3002727
Vancouver
Rajani RM, Ellingford R, Hellmuth M, Harris SS, Taso OS, Graykowski D, et al. Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease. PLOS Biology. 2024;22(7):e3002727. doi:10.1371/journal.pbio.3002727
BibTeX
@article{Rajani2024,
author = {Rajani, Rikesh M and Ellingford, Robert and Hellmuth, Mariam and Harris, Samuel S and Taso, Orjona S and Graykowski, David and Lam, Francesca Kar Wey and Arber, Charles and Fertan, Emre and Danial, John S H and Swire, Matthew and Lloyd, Marcus and Giovannucci, Tatiana A and Bourdenx, Mathieu and Klenerman, David and Vassar, Robert and Wray, Selina and Sala Frigerio, Carlo and Busche, Marc Aurel},
title = {Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease},
journal = {PLOS Biology},
year = {2024},
volume = {22},
number = {7},
pages = {e3002727},
doi = {10.1371/journal.pbio.3002727}
}
EUVIMED